Obimin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Obimin

What is Obimin: Definition and Pharmacological Type

Obimin is classified as a Multivitamin and Mineral Supplement, representing a multi-component preparation intended for comprehensive Nutritional Support. This specific formulation is positioned toward supporting general nutritional needs through a blend of essential substances. Its categorization places it within the Polyvitamin-Polymineral Preparations pharmacological class. It is composed of a complex blend of synthetic and derived essential micronutrients and is manufactured as an oral solid dosage form (tablet or capsule) for oral administration.


What is the Composition and Form of Obimin?

The composition of Obimin ensures the delivery of both essential vitamins and key minerals within a single entity. The formula includes a broad B-complex profile (Thiamine, Riboflavin, Pyridoxine, Cyanocobalamin, Folic Acid, Niacinamide, Calcium Pantothenate), alongside Retinol (Vitamin A), Ascorbic Acid (Vitamin C), and Cholecalciferol (Vitamin D). Mineral components, which are necessary for systemic function, include Iron (as Ferrous Fumarate), Calcium (as Calcium Lactate), Copper, and Iodine. The inclusion of these minerals alongside the vitamins is a primary feature of this formulation.


What is the General Purpose of Taking Obimin?

The general purpose of taking Obimin is to provide Direct Nutrient Replenishment to ensure the body has an adequate supply of necessary substances when dietary intake is insufficient or physiological needs are heightened. Adequate levels of these essential micronutrients are required for systemic function, and addressing nutritional gaps is a primary method for maintaining health. This combination approach is intended for optimizing micronutrient status and managing the Correction of hypovitaminosis and associated mineral deficits. This supportive mechanism helps maintain overall biochemical balance and general health.

Regulatory References

  1. WHO Micronutrients Overview
  2. MedlinePlus Vitamins and Minerals

What side effects are possible with Obimin?

Possible Side Effects and Safety Information

The officially documented safety profile for this multivitamin and mineral preparation is primarily defined by the adverse reactions associated with its iron and other mineral components, as outlined in government regulatory labeling. Adverse events are classified using standard regulatory frequency categories, such as Common, Uncommon, and Rare.

Adverse Reaction Classification

Classification System-Organ Class Involved Documented Effects
Common Gastrointestinal Disorders Nausea, constipation, diarrhea, dyspepsia, abdominal discomfort, and darkening of stools.
Uncommon Nervous System Disorders Headache.
Rare Immune System Disorders Allergic reactions (hypersensitivity) and severe hypersensitivity/anaphylaxis.

The most frequently reported side effects fall under Gastrointestinal Disorders and may be observed at the start of treatment, often diminishing with continued use. The observation of dark or black stools is a non-harmful, expected consequence of oral iron supplementation and is officially documented.

Serious Safety Constraints

Regulatory documents mandate specific safety constraints. Accidental overdose of iron-containing products, including this one, is explicitly highlighted as a leading cause of fatal accidental poisoning in children under six years of age. Therefore, the product must be kept out of their reach.

Furthermore, the preparation is contraindicated in individuals with a known hypersensitivity to any component and in patients with pre-existing iron-overload states (such as Hemochromatosis or Hemosiderosis). High doses of certain components can cause bright yellow discoloration of the urine, which is a non-harmful, expected effect that may interfere with some laboratory tests.

Overdose and Emergency Response

The official overdose profile for polyvitamin-mineral preparations like Obimin is primarily driven by the corrosive and systemic toxicity of the Iron component. Overdose manifests in documented stages, beginning with severe gastrointestinal effects such as bloody vomiting, diarrhea, and abdominal pain, which may lead to extreme lethargy. Following these initial symptoms, a deceptive latent phase may occur before the onset of critical systemic toxicity. The high content of Vitamin A may additionally contribute to documented manifestations like dizziness and blurred vision.

Regulators classify iron overdose as a potentially severe and life-threatening event, with documented outcomes including cardiovascular shock, metabolic acidosis, hepatic necrosis, and coma. Accidental ingestion by a child under six years old is an immediate medical emergency and is documented as a leading cause of fatal poisoning in this population. Immediate medical attention must be sought upon any suspected overdose.

Management requires urgent hospitalization for continuous monitoring, including measurement of serum iron concentrations and X-ray imaging. Treatment is supportive, and the specific chelating agent Deferoxamine is documented as the antidote for severe iron toxicity. Symptomatic and supportive care is required to maintain vital functions.

Therapeutic Uses of Obimin

What Obimin Treats: Main Uses and Benefits

Obimin is commonly used to provide essential vitamin and mineral support to address the significantly increased nutritional demands during pregnancy and lactation. This formulation may assist with managing symptom clusters linked to common deficiencies, such as physical weakness and fatigue associated with nutritional iron-deficiency anemia.

The main areas of use include support for critical fetal development, support in meeting the increased nutritional needs in the mother, and postnatal recovery during breastfeeding. This supportive benefit helps ease the overall symptom burden, supports general well-being, and helps maintain a sense of stability, particularly when symptoms of nutritional strain interfere with daily functioning.

“By supplying nutrients relevant for the growth of the developing baby, this support is considered relevant during the stages of fetal development.”

The medication is relevant in clinical settings marked by increased physiological stress and is applied in the postpartum period to assist the mother in replenishing nutrient stores. It offers continued supportive relief by supporting the body's continued nutritional needs during lactation.

Quick Fact: Relief for Fatigue and Weakness

Eligibility and Restrictions for Use

Who Can and Cannot Use Obimin?

The eligibility for Obimin is primarily determined by its official classification as a pre- and postnatal multivitamin and mineral supplement, as documented in regulatory guidelines.

Population Status Eligibility Rule (Official Basis)
Permitted Use Pregnant Women (Pre-natal support), Lactating Women (Post-natal support), and Women Planning Pregnancy.
Contraindicated Use Patients with known hypersensitivity or allergy to any active or inactive ingredient in the formulation.

Conditional Use and Restrictions:

Official labeling mandates specific population restrictions where the medicine must not be used or requires caution:

  1. Hypervitaminosis: Use is strictly contraindicated in individuals with pre-existing excessive levels of fat-soluble vitamins, specifically Hypervitaminosis A or D, due to the potential for component toxicity.
  2. Megaloblastic Anemia: Use is restricted in patients suspected of having megaloblastic anemia until a Vitamin B12 deficiency has been ruled out, as the folic acid component may mask symptoms.
  3. Age-Related: Use is not established for general pediatric populations, as the product's indication is specific to adult women of reproductive age.

The official eligibility structure emphasizes safety by explicitly prohibiting use in patients with known allergies or existing nutrient overloads, while formally establishing use for the target reproductive population.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Obimin identifies several clinically significant interactions, primarily based on the actions of its mineral and vitamin components. These interactions may result in decreased absorption or reduced therapeutic efficacy of co-administered medicines.

Exposure-Modifying Interactions

The mineral components, Iron and Calcium, can bind to and reduce the oral bioavailability of several drugs, including thyroid hormone replacements such as Levothyroxine and specific antibiotics like Fluoroquinolones and Tetracyclines. This binding mechanism requires mandatory timing separation between doses.

Folic Acid and Pyridoxine (Vitamin B6) content may affect the exposure of other medicinal products. Folic Acid can lead to decreased plasma levels of the anticonvulsant Phenytoin and may diminish the therapeutic effect of the antimetabolite Methotrexate. Pyridoxine may reduce the efficacy and blood levels of Levodopa in certain formulations. The multivitamin class carries a regulatory caution regarding the potential for interference with anticoagulants like Warfarin, dependent on the presence of Vitamin K.

Administration Constraints

To mitigate the risk of reduced drug absorption, official labeling requires that Obimin be administered separated by at least 2 to 6 hours from co-administered agents, including Bisphosphonates and the susceptible antibiotics.

Mechanism of Action

The mechanism of Obimin is one of biochemical replenishment, acting by providing essential cofactors and structural substrates to facilitate the body's baseline enzymatic and metabolic processes.

This action engages enzymes in the TCA cycle and Oxidative Phosphorylation via B-complex coenzymes (e.g., FAD, NAD^+), which are required for the conversion of energy substrates into cellular ATP. Folic Acid and B12 cofactors are also provided, which are essential for DNA/RNA synthesis and support the proliferation of cells with high turnover rates, such as erythroid precursors.

The formula supplies Iron for incorporation into Hemoglobin, necessary for maximal systemic oxygen-carrying capacity, and Iodine as a precursor for thyroid hormones (T3/T4) synthesis. Cholecalciferol (Vit D) acts as a precursor to the VDR ligand that regulates Calcium balance, a process required for excitation-contraction coupling in muscle cells and nerve impulse transmission.

This function is distinguished by the mechanistic interdependence of components, particularly in hematopoiesis, where Iron, B-vitamins, and Folic Acid are all required for red blood cell maturation.

Dosage and Administration Information

How Obimin is Used: Official Administration Guidelines

This section describes the standard administration of Obimin and its formulations, such as Obimin Plus. The information presented here relates only to the prescribed pattern of use and not to therapeutic effects or safety.


Administration Scope

The approved route for this multivitamin and mineral preparation is oral, meaning the product must be swallowed. The standard administration regimen specifies taking one tablet or softgel capsule daily. This schedule establishes the dosing as a once-daily pattern for the duration of use.

Timing instructions advise that the product may be taken with a meal or with food, which is recommended to support proper absorption of the mineral components. If a dose is missed, standard instructions advise the user not to double the dose to compensate, but instead to resume the standard next scheduled dose at the usual time.


Procedural Context and Duration

Obimin is classified for use as pre- and postnatal nutritional support, meaning the regimen is directed toward pregnant and lactating women as the target population. Use typically begins during pregnancy and is intended as a long-term supportive course, continuing through the postpartum period of lactation. The formulation does not require any special preparation steps, such as dilution or crushing, and is administered as a whole unit.


Procedural Summary

  1. Take one tablet or softgel of the product.
  2. Administer the dose orally and according to the once-daily schedule.
  3. Consume the product with a meal for best practice, though flexibility may exist.
  4. Maintain the regimen as a long-term supportive course throughout the specified physiological period.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Obimin


The available research evidence for polyvitamin-polymineral (MMN) preparations, aligning with the composition and use of Obimin, is largely derived from Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews.

1. Evidence for Nutritional Support During Pregnancy

The primary evidence for this class of supplement during pregnancy was evaluated in extensive RCTs, often comparing MMNs against the standard supplement containing only iron and folic acid (IFA). Studies explored outcomes related to systemic or functional imbalance in the mother, such as the changes observed in iron status and levels of various vitamins (e.g., vitamin D and B-complex vitamins). Findings describe patterns observed in the studies where MMN supplementation was associated with different measures of maternal biochemical indicators compared to the standard IFA.

Researchers monitored fetal growth outcomes including Low Birth Weight (LBW) and Small-for-Gestational-Age (SGA) births. In research conducted in areas with high rates of undernourishment, some trials described patterns suggesting differences in LBW and SGA when MMNs were compared to IFA. However, research exploring more serious outcomes, such as stillbirth or perinatal death, often found that findings were mixed or that the data show patterns related to outcomes that are not statistically different between MMN and IFA groups.

2. Evidence for Postpartum and Lactation Support

Research has explored the continued use of MMNs after delivery, focusing on the period of heightened nutritional demand. Studies monitored maternal micronutrient status and recovery of stores. Findings indicate that supplementation was associated with maintaining higher measures of certain vitamins and minerals in maternal serum. Research also examined nutrient concentration in breast milk and its association with supplementation, showing increased concentration of some nutrients in human milk.

3. What Remains Uncertain and Research Gaps

Research acknowledges that the typical follow-up durations were limited for many trials, and long-term effects remain to be fully established. The evidence quality varies across studies due to differences in micronutrient formulas and dosages, leading to heterogeneity. Furthermore, data for certain groups remain insufficient, particularly for populations with lower baseline nutritional risk. Certainty remains low regarding the potential for MMNs to influence major clinical endpoints like preterm birth consistently across all populations.

Frequently Asked Questions (FAQ)

Common questions about Obimin (FAQ)


Q: Does Obimin interact with common pain relievers like paracetamol?

Official regulatory documents generally focus on specific drug classes that interact with the supplement’s mineral content, such as certain antibiotics or thyroid hormones. Studies related to the individual components of Obimin, like Folic Acid, typically do not show a direct interaction with paracetamol. Users may wish to consult their healthcare provider before combining this supplement with any other medicines.


Q: Should I avoid certain foods or drinks while taking Obimin?

Official administration instructions advise that Obimin may be taken with a meal to help with mineral absorption. While no specific foods are strictly forbidden, certain nutrients, such as very high amounts of calcium, may reduce the absorption of iron, one of the key minerals in Obimin. Questions about optimizing timing relative to your diet are best addressed by a healthcare provider.


Q: Does Obimin contain any ingredients that might cause an allergic reaction?

Yes. According to regulatory safety information, the product is contraindicated (should not be used) in individuals with a known hypersensitivity or allergy to any active or inactive ingredient in the formulation. Patients with known allergies are advised to review the full list of ingredients on the product label or discuss concerns with a healthcare provider.


Q: Are there any high-risk groups who should avoid Obimin?

Official regulatory information identifies specific safety constraints where use is strictly prohibited. This includes patients with a known hypersensitivity, those with pre-existing iron-overload states (like Hemochromatosis), or conditions of Hypervitaminosis A or D (excessive vitamin levels). The product’s core indication is specific to adult women of reproductive age, and its use is not established for general pediatric populations.


Q: Can Obimin interfere with blood tests or medical procedures?

Yes, it can. Official safety documentation notes that high doses of certain B vitamins can lead to a bright yellow discoloration of the urine. While harmless, this color change may interfere with the results of some laboratory tests. Users taking this supplement may consider informing their doctor or lab technician, particularly if they notice urine discoloration.


Q: Is it possible to take too many vitamins if I take Obimin with a fortified diet?

Since Obimin contains key fat-soluble vitamins, its use is contraindicated if you have pre-existing Hypervitaminosis A or D due to the potential for toxicity. If your diet already includes highly fortified foods or other supplements, discussing this with a healthcare provider may help ensure safe intake levels of fat-soluble vitamins are not exceeded.


Q: Can Obimin be split or crushed if someone has trouble swallowing pills?

The official product administration instructions specify that the supplement is typically administered as a whole unit (one tablet or softgel capsule). As with any oral solid dosage form, crushing or splitting is typically not addressed in the product’s instructions and may potentially alter the intended absorption or stability. Consult the manufacturer’s instructions or a pharmacist.


Q: Is there a maximum time someone can safely take Obimin?

Regulatory documents establish the use of Obimin as a long-term supportive course directed toward pregnant and lactating women. While there is no absolute cut-off date stated in the core regulatory information, the supplement is intended to be maintained throughout the specified physiological period to ensure consistent nutrient replenishment.


Q: Does Obimin interact with caffeine or alcohol?

Regulatory labels for key components like Folic Acid and B-vitamins may caution that excessive consumption of alcohol can potentially decrease the absorption and increase the elimination of these nutrients from the body. Specific warnings regarding caffeine interaction are not commonly found in the regulatory documentation for this product class.


Q: Why does Obimin need to be taken consistently?

The product is designed to be taken as a long-term supportive course for biochemical replenishment. Consistent, once-daily administration helps ensure a steady supply of essential cofactors and substrates (vitamins and minerals) to support continuous metabolic processes and, where applicable, fetal growth.


Q: What are the benefits of the trace elements in Obimin?

Official documentation describes the function of the trace elements. Iron is supplied to support the formation of Hemoglobin (for oxygen-carrying capacity), and Iodine acts as a precursor required for the synthesis of thyroid hormones. Other trace elements like Copper are included as necessary cofactors for various body-wide enzymatic processes.


Q: Is Obimin used outside of pregnancy?

The official indication is specific, targeting pregnant women, lactating women, and women planning pregnancy for nutritional support. Use for general nutritional needs outside of these defined reproductive groups is not formally addressed in the product’s core regulatory documentation.

How should Obimin be stored and disposed of?

How to Store and Dispose of Obimin?

The official regulatory guidelines for Obimin define specific environmental and safety constraints to maintain product stability.

Required Storage and Protection

The product must be stored at temperatures not exceeding 30 C to comply with labeled stability conditions. To prevent accidental ingestion, the medicine must be kept out of reach and sight of children, as required by official child-safety storage rules.

Storage Classification Requirement
Maximum Temperature Not exceeding 30 C
Child Safety Keep out of reach and sight of children

Disposal of Product

It is prohibited to use the medication after the expiry date printed on the label. Any unused or expired product must be discarded in accordance with local regulatory guidelines for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Obimin found in:

A-Z Index: